Lung Cancer

Dr. Nathan A. Pennell discusses the key genetic markers for treating patients with non-small cell lung cancer with targeted therapies.

The Food and Drug Administration approves Gavreto for treatment of patients with metastatic, RET fusion-positive non-small cell lung cancer.

The novel next-generation ALK tyrosine kinase inhibitor improved survival, compared with Xalkori, in patients with ALK-positive non-small cell lung cancer, potentially representing a new option in the first-line setting.

The test was also approved as a companion diagnostic test to determine which select patients with metastatic castration-resistant prostate cancer could benefit from Rubraca, as well as for three frontline TKIs in patients with non-small cell lung cancer.

The FDA has approved a generic form of the intravenous chemotherapy pemetrexed for use by itself in patients with locally advanced or metastatic non-squamous non-small cell lung cancer that has not progressed following four cycles of initial platinum-based chemotherapy.

Specific measures of a tumor’s texture and intensity as they appear on CT images can help determine how much treatment patients with early stage lung cancer need, a study found.

In this episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Dan Tran about his journey with stage 4 lung cancer and what advice he offers other survivors and patients with cancer.

If approved by the FDA, Imfinzi could be administered every four weeks at a fixed dose in patients with stage 3 NSCLC after they received chemoradiation, as well as in patients with previously treated bladder cancer.

The Food and Drug Administration granted a priority review to the new drug application for trilaciclib for patients with small cell lung cancer.

“Therapeutic trials are very, very important because thanks to them, our patients are living longer,” said Dr. Narjust Duma. “But (physicians) also need to stop and ask how our patients are living.”

From Johnson & Johnson discontinuing their talc-based baby powder in the U.S. and Canada after numerous lawsuits that cited the talc, a mineral similar to asbestos, caused cancer, to the ramifications of delayed cancer surgeries being felt by patients, here’s everything happening in the cancer space this week.

Understanding lung cancer.

Here is a list of clinical trials that are currently happening within the mesothelioma space.

New therapies approved following innovative research are increasing survival rates for patients with advanced lung cancer.

How a cancer diagnosis leaves one woman feeling humbled.

From plans to sue the School District of Philadelphia over a mesothelioma diagnosis to Dwayne “The Rock” Johnson singing for a 3-year-old with acute lymphoblastic leukemia, here’s what is making headlines in the cancer space this week.

Disparities in lung cancer care must be closed to improve patient outcomes.

The keynote speaker at the CURE® Patient-Focused Sessions at the Annual New York Lung Cancers Symposium® heeded warning signs and urges others to do the same.

Researchers combine therapies in clinical trials to find the best match for patients with small cell lung cancer.

An aptly named app brings community to patients and caregivers around the world.

From the latest report on the “State of Lung Cancer” to NASA-style workouts for patients with cancer, here’s what is making headlines in the cancer space this week.

Researchers have discovered that a diet rich in fiber and yogurt may protect against lung cancer.

For Lung Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.

From a palliative care bill clearing the House to a Washington Redskins player revealing a cancer diagnosis, here’s what is making headlines in the cancer space this week.

The same properties that make certain cancers hard to treat may also promote their death by ferroptosis, scientists at the Sloan Kettering Institute have found.